Longevity has never had a science problem so much as a business model problem. No regulator anywhere approves a drug for...
Every host city wants the same thing from an event like this: not the visit, but the verdict. What made the press meet w...
A CEPI-backed vaccine candidate developed by the University of Oxford’s Oxford Vaccine Group has become the first ...
US-based GEM Global Yield LLC SCS has executed a Share Purchase Agreement (SPA) with the existing shareholders of Taiwan...
South Korea-based startup Boostimmune has secured a Japanese patent covering technology that uses antibodies to inhibit ...
Japan-based Shimadzu Corporation has completed the acquisition of all shares of Glass HoldCo s.r.o., which indirectly ho...
China-based startup OTR Therapeutics has entered into a strategic collaboration agreement with Korean company LG Chem to...
There is a particular energy to the first thirty minutes of a conference that knows exactly what it wants to say. As the...
South Korea-based Samsung Bioepis has entered into a license agreement with Proteina Co. to collaborate on a government-...
As gastroenterology providers across Australia and New Zealand face growing patient demand and increasing documentation ...
South Korea-based Daewoong Pharmaceutical has entered into a distribution agreement with Waycen Inc., a medical AI compa...
Virax Biolabs has announced that its wholly owned subsidiary, Virax Biolabs (UK) has entered into an exclusive multi-cou...
India's Godavari Biorefineries has been granted a patent by the Japan Patent Office for its breakthrough invention, "5-H...
Agilent Technologies Inc. has announced the latest expansion of its Altura HPLC column portfolio with the introduction o...
Australian biotech Aegros has completed Australia’s second human plasma fractionation facility, joining CSL’...
Bristol Myers Squibb (BMS), a global biopharmaceutical leader, recently celebrated its 60th anniversary in Singapore by ...
Artificial intelligence is rapidly reshaping the way biopharma companies discover, develop, and manufacture medicines. H...
Advancing Clinical Development and Evidence Generation Clinical development is entering a new era where success depends...
Taiwan-based HanchorBio, Inc. is taking another step to broaden the development path for HCB101, its lead oncology asset...
Lotus Pharmaceutical, a global pharmaceutical company headquartered in Taiwan, has announced that its wholly owned subsi...
Japan-based Tanabe Pharma has decided to transfer the domestic manufacturing and marketing approvals, manufacturing and ...
As cell and gene therapies progress from promising research to commercial reality, manufacturing has emerged as ...
As antibody-drug conjugates (ADCs) transition from a promising therapeutic modality to a cornerstone of precision oncolo...
As antibody-drug conjugates (ADCs), bispecific antibodies and other advanced biologics redefine the global therapeutics ...
The rapid expansion of in vivo gene therapy is reshaping expectations for viral vector manufacturing, placing greater em...
